131 related articles for article (PubMed ID: 28321376)
1. Role of Glioblastoma Craniotomy Related to Patient Survival: A 10-Year Survey in a Tertiary Care Hospital in Pakistan.
Shahid S; Hussain K
J Neurol Surg B Skull Base; 2017 Apr; 78(2):132-138. PubMed ID: 28321376
[TBL] [Abstract][Full Text] [Related]
2. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Association Between the Extent of Resection and Survival in Gliosarcoma.
Ahmed FI; Abdullah KG; Durgin J; Salinas RD; O'Rourke DM; Brem S
Cureus; 2019 Apr; 11(4):e4374. PubMed ID: 31218139
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
[TBL] [Abstract][Full Text] [Related]
6. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
8. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
9. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
10. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
Kim YJ; Lee DJ; Park CK; Kim IA
Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
[TBL] [Abstract][Full Text] [Related]
11. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
[TBL] [Abstract][Full Text] [Related]
12. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
13. Perioperative seizure in patients with glioma is associated with longer hospitalization, higher readmission, and decreased overall survival.
Dewan MC; White-Dzuro GA; Brinson PR; Thompson RC; Chambless LB
J Neurosurg; 2016 Oct; 125(4):1033-1041. PubMed ID: 26894454
[TBL] [Abstract][Full Text] [Related]
14. Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.
Southwell DG; Birk HS; Han SJ; Li J; Sall JW; Berger MS
J Neurosurg; 2018 Sep; 129(3):567-575. PubMed ID: 29125414
[TBL] [Abstract][Full Text] [Related]
15. Application of Delta T1 maps for quantitative and objective assessment of extent of resection and survival prediction in glioblastoma.
Laing BR; Prah MA; Best BJ; Krucoff MO; Mueller WM; Schmainda KM
Neurosurg Pract; 2024 Mar; 5(1):. PubMed ID: 38919518
[TBL] [Abstract][Full Text] [Related]
16. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
17. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
[TBL] [Abstract][Full Text] [Related]
18. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
[TBL] [Abstract][Full Text] [Related]
19. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
Dhandapani S; Singh H; Negm HM; Cohen S; Souweidane MM; Greenfield JP; Anand VK; Schwartz TH
J Neurosurg; 2017 Feb; 126(2):418-430. PubMed ID: 27153172
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
